SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
CYTOCLONAL PHARMACEUTICS INC.
-----------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
------------------------------
(Title of Class of Securities)
23282G105
--------------
(CUSIP Number)
Andrea Kramer, c/o Roan Meyers Associates, L.P.,
17 State Street, 19th Floor, New York, NY 10004
(212) 742-4200
-------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 28, 2000
------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and
is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box. []
CUSIP No...................................
23282G105
-----------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of above
persons (entities only).
Bruce Meyers SS####-##-####
----------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) N/A
(b) N/A
----------------------------------------------------------------------
3. SEC Use Only
.......................................................................
4. Source of Funds (See Instructions)
.......................................................................
PF (Long-term investment)
-----------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) ...............
N/A
-----------------------------------------------------------------------
6.Citizenship or Place of Organization
.......................................................................
USA
-----------------------------------------------------------------------
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7. Sole Voting Power
.......................................................................
1,965,248 shares Common stock, which number includes: 26,620
shares Preferred stock convertible into Common stock on a share-for-
share basis, 25,326 Underwriter Purchase Options which may be converted
to Common stock on a four-for-one basis with payment to Issuer, and
41,847 non-public "E" Warrants convertible into Common stock on a one-
for-one basis with payment to Issuer.
-----------------------------------------------------------------------
8. Shared Voting Power
.......................................................................
401,012 shares Common stock, which number includes 57,300 shares
Common stock owned by the Joseph, Rita and Bruce Meyers Foundation for
Life Inc., and securities held by Roan/Meyers Associates, L.P., a
securities broker-dealer of which Bruce Meyers is General Partner.
-----------------------------------------------------------------------
9. Sole Dispositive
Power..................................................................
1,965,248 (See Item 7, above.)
-----------------------------------------------------------------------
10. Shared Dispositive Power
.......................................................................
401,012 (See Item 8, above.)
----------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,965,248
-----------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) ...........
N/A
----------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
............................................................
12.6
-----------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
IN
.......................................................................
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
May 11, 2000
----------------------------------------------------------------------
Date
Bruce Meyers
-----------------------------------------------------------------------
Signature
Bruce Meyers
-----------------------------------------------------------------------
Name/Title
Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001)
